NCT00457860View on ClinicalTrials.gov

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2007

Conditions
Leukemia
Interventions
DRUG

Immunotoxin therapy

DRUG

CAT-8015 immunotoxin

PROCEDURE

Biological therapy

Trial Locations (4)

20892

RECRUITING

Warren Grant Megnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

46202

NOT_YET_RECRUITING

Indiana University Cancer Center, Indianapolis

90211

RECRUITING

Tower Hematology Oncology Medical Group, Beverly Hills

Unknown

NOT_YET_RECRUITING

Klinika Hemtologii Uniwersytetu Medycznego (Medical University of Lodz), Lodz

Sponsors
All Listed Sponsors
lead

Cambridge Antibody Technology

OTHER

NCT00457860 - Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease | Biotech Hunter | Biotech Hunter